.

FY26 consolidated revenue from operations was 622.57 crore, EBITDA was 87.82 crore and profit after tax was 25.38 crore.

EBITDA increased to 87.82 crore from 58.59 crore and PAT increased to 25.38 crore from 12.50 crore. EBITDA margin rose to 14.11% from 11.05% and PAT margin rose to 4.08% from 2.36%.

Q1 FY27 revenue from operations was 179.09 crore, EBITDA was 22.21 crore and PAT was 7.27 crore. Revenue grew 22.20% YoY, while PAT declined 40.56% YoY.

The presentation lists B2B terpene products (including camphor, dipentene and others), B2B synthetic resin products (including terpene phenolic resin, alkyl phenolic resin and rosin ester) and B2C retail operations under brands such as CamPure and Mangalam.

It mentions expanding the product portfolio, expanding geographic reach by growing distribution with 190 salespeople to penetrate 14 states, strengthening e-commerce presence in India and pursuing export opportunity, including starting sales in the USA and UK.

FY26 net cash from operating activities was 0.91 crore, impacted by a working capital outflow of -85.85 crore, despite profit before tax of 33.30 crore.

Borrowings increased to 55 crore (non-current) and 301 crore (current) from 35 crore and 234 crore respectively in March 2025. Inventories increased to 300 crore from 213 crore.